中国药典的发展历史及启示  

Development history and enlightenment of the Chinese Pharmacopoeia

作　　者：赵宇新[1] 麻广霖[1] 张伟[1] ZHAO Yuxin;MA Guanglin;ZHANG Wei(Chinese Pharmacopoeia Commission,Beijing 100061,China)

机构地区：[1]国家药典委员会,北京100061

出　　处：《中国药品标准》2020年第6期481-486,共6页Drug Standards of China

摘　　要：《中国药典》是保障药品质量的技术法典,经历了民间本草典籍作为事实药典、官修本草和方书作为法定药典、近现代药典雏形以及现代化药典几个阶段。通过对中国药典的发展历史进行分析,结合药品监管实践,认为药典具有保障药品质量、引领技术标准体系发展和推动医药产业进步等功能,并提出后续药典工作中需注意的问题。As the technical code to guarantee the quality of drugs,the Chinese pharmacopoeia has gone through several stages of folk Materia Medica as fact Pharmacopoeia,official revised materia medica as legal Pharmacopoeia,prototype of the modern Pharmacopoeia and the modern Pharmacopoeia.The development history of the Chinese Pharmacopoeia is analyzed in combination with drug administration practice.It is considered that the Chinese Pharmacopoeia has the functions of guaranteeing the drug quality,guiding the pharmaceutical standard system development and promoting the progress of pharmaceutical industry.Several worth-concerning problems in development of pharmacopoeia are underlined accordingly.

关 键 词：中国药典 发展历史 作用 

分 类 号：R921.2[医药卫生—药学]